Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN study supporting a slowing decline…
PUNO, a fast-growing experiential entertainment brand, today announced the launch of its Social Zone at PUNO Advance, Pune—the city’s first…
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name…
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel nasal spray designed to rapidly…
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)…
- Two-year lifestyle intervention "recipe" tested in three NIH-funded ancillary studies -Key TakeawaysFindings from three NIA-funded ancillary studies to the U.S.…
New York City, NY, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Memory Lift brain productivity nootropics supplement launches for adults seeking…
BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Rendever, the company leading the industry in immersive technology for aging, has secured…
New York City, NY, Nov. 01, 2025 (GLOBE NEWSWIRE) -- Introduction – Is Poor Sleep Ruining Your Days? If you’ve…
Sanofi recently hosted a hybrid symposium titled "Safeguarding High-Risk Groups: The Importance of Flu Prevention and Effective Communication," bringing together…